Page last updated: 2024-09-03

imatinib mesylate and Cancer of Parotid

imatinib mesylate has been researched along with Cancer of Parotid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhayani, MK; Montague, GL; Pease, G1
Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ1

Other Studies

2 other study(ies) available for imatinib mesylate and Cancer of Parotid

ArticleYear
New Facial Weakness After 5 Years of Facial Asymmetry.
    JAMA otolaryngology-- head & neck surgery, 2016, 11-01, Volume: 142, Issue:11

    Topics: Adult; Antineoplastic Agents; Dermatofibrosarcoma; Facial Asymmetry; Facial Paralysis; Humans; Imatinib Mesylate; Male; Parotid Neoplasms; Time Factors

2016
[Acquired ichthyosis and haematological malignancies: five cases].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:1

    Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine

2012